SCHEMBL4167435

SCHEMBL4167435

COc1c(-c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)oc2ccccc2c1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 8/20 0.70
MAPT P10636 4/20 0.57
TP53 P04637 2/20 0.57
RXFP1 Q9HBX9 1/20 0.57
KDM4E B2RXH2 5/20 0.55
CYP3A4 P08684 4/20 0.55
HSD17B10 Q99714 4/20 0.55
ALDH1A1 P00352 4/20 0.55
HPGD P15428 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 1/20 0.55
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
ABCB1 P08183 3/20 0.54
CYP2C9 P11712 2/20 0.53
TSHR P16473 2/20 0.53
CYP2C19 P33261 2/20 0.53
ABCC1 P33527 2/20 0.51
THRB P10828 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16150328 0.92 TP53 (0.58) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL4153233 0.91 ABCG2 (0.63) ABCG2MAPTKDM4ECYP3A4HSD17B10
SCHEMBL4158838 0.87 TP53 (0.56) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL4158840 0.87 TP53 (0.55) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL1976582 0.87 ABCG2 (0.61) ABCG2MAPTTP53KDM4ECYP3A4
SCHEMBL7688870 0.86 KCNA3 (0.54) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL4167438 0.86 KDM4E (0.67) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL2397393 0.85 MAPT (0.75) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL7688926 0.85 KCNA3 (0.53) ABCG2MAPTTP53RXFP1KDM4E
SCHEMBL10769734 0.85 ABCG2 (0.72) ABCG2MAPTKDM4ECYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090130051-A1 Flavonoid Compounds and Uses Thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2009-05-21 US claimed
US-20020147353-A1 Novel flavonoids VERENIGING CHRISTELIJK WETENSCHAPPELIJK ANDERWIJS (NL) 2002-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147353-A1 Novel flavonoids H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, ABCC8 ABCG2 326/4885MAPT 4588/4885TP53 730/4885
US-20090130051-A1 Flavonoid Compounds and Uses Thereof CAT, NQO1, GPX4 ABCG2 102/4885MAPT 3887/4885TP53 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.